ASTMH 2017

66th Annual Meeting
November 5-9, 2017
Baltimore, Maryland, USA
DNDi will be presenting on Chagas disease.

ECTMIH 2017

10th European Congress on Tropical Medicine and International Health
October 16-20, 2017
Antwerp, Belgium
DNDi will be participating at the event.

Daiichi Sankyo announces collaborative research on drugs for neglected diseases

[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.

Study confirms key therapeutic advance for children living with HIV and tuberculosis

[Seattle, USA – February 14, 2017]
Landmark study proves that “super-boosting” approach counters negative interaction between key HIV and TB drugs
The non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) has released results of a study in South Africa that will make it easier for healthcare workers to treat children living with HIV who are co-infected with tuberculosis.

The 7th KASH Conference

KEMRI Annual Scientific and Health Conference

February 8-10, 2017
Nairobi, Kenya
Gina Ouattara, Project Coordinator for HIV/HCV, and Kevin Onyango, Project Coordinator for Mycetoma, both from the DNDi Africa office, presented at the event.

2016 in Review

Our staff, partners, and stakeholders share their highlights from 2016.